Антипсихотическая терапия с использованием атипичных нейролептиков

Полный текст:
Читать

Рекомендуемое оформление библиографической ссылки:

Ястребов Д.В. Антипсихотическая терапия с использованием атипичных нейролептиков // Российский психиатрический журнал. 2013. №1. С. 71-82.

Аннотация

В обзорной статье рассматриваются аспекты антипсихотической терапии с использованием атипичного антипсихотического препарата рисперидона и обсуждается тактика его назначения и последовательного ведения пациентов.

Ключевые слова антипсихотическая терапия; атипичные нейролептики; респиридон

Литература

1. Авруцкий Г.Я., Недува А.А. Лечение психически больных. - М.: Медицина, 1988. - 528 с. 2. Мосолов С.Н. Основы психофармакотерапии. - М.: Восток, 1996. - 288 с. 3. Ястребов Д.В. Терапия обсессивных и тревожных расстройств у больных с непсихотическими формами шизофрении // Психиатрия и психофармакотер. - 2011. - Т. 13, № 4. - С. 38-47. 4. Ястребов Д.В. Монотерапия рисперидоном (ридонексом) обсессивных и тревожных расстройств у больных шизофренией // Совр. тер. псих. расстройств. - 2012. - № 1. - С. 22-30. 5. Alevizos B., Lykouras L., Zervas I.M. et al. Risperidone-induced obsessive-compulsive symptoms: a series of six cases // J. Clin. Psychopharmacol. - 2002. - Vol. 22. - P. 461-467. 6. Baker R.W., Ames D., Umbricht D.S. et al. Obsessive-compulsive symptoms in schizophrenia: a comparison of olanzapine and placebo // Psychopharmacol. Bull. - 1996. - Vol. 32. - P. 8 9 - 9 3 . 7. Cutler J., Siris S.G. "Panic-like" symptomatology in schizophrenic and schizoaffective patients with postpsychotic depression: observations and implications // Compr. Psychiatry. - 1991. - Vol. 32. - P. 465-473. 8. Cutler J. Panic attacks and schizophrenia: assessment and treatment // Psych. Ann. - 1994. - Vol. 24. - P. 473-476. 9. Essock S.M., Covell N.H., Davis S.M. et al. Effectiveness of switching antipsychotic medications // Am. J. Psychiatry. - 2006. - Vol. 163 (12). - P. 2090-2095. 10. Farde L., Nordstrom A.L., Wiesel F. A. et al. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: relation to extrapyramidal side effects // Arch. Gen. Psychiatry. - 1992. - Vol. 49. - P. 538-544. 11. Gaebel W., Riesbeck M., Wоlwer W. et al. Relapse prevention in first-episode schizophrenia - maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia // J. Clin. Psychiatry. - 2011. - Vol. 72 (2). - P. 205-218. 12. Ganguli R. Rationale and strategies for switching antipsychotics // Am. J. Health Syst. Pharm. - 2002. - Vol. 59. - P. S22-S26. 13. Gautam D., Han S.J., Hamdan F.F. et al. A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo // Cell Metab. - 2006. - Vol. 3 (6). - P. 449-461. 14. Ghaemi S.N., Zarate C.A., Popli A.P. et al. Is there relationship between clozapine and obsessive compulsive disorder? A retrospective chart review // Compr. Psychiatry. - 1995. - Vol. 36. - P. 2 6 7- 2 7 0 . 15. de Greef R., Maloney A., Olsson-Gislekog P. et al. Dopamine D2 Occupancy as a Biomarker for Antipsychotics: Quantifying the Relationship with Efficacy and Extrapyramidal Symptoms // AAPS J. - 2011. - Vol. 13, N 1. - P. 121-130. 16. de Haan L., Beuk N., Hoogenboom B. et al. Obsessivecompulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders // J. Clin. Psychiatry. - 2002. - Vol. 63. - P. 104-107. 17. de Haan L., Linszen D. H., Gorsira R. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders // J. Clin. Psychiatry. - 1999. - Vol. 60. - P. 364. 18. Haase H.J., Janssen P.A.J. The Action of Neuroleptic Drugs. - Chicago, IL: Year Book Medical, 1965. 19. Hiemke C., Weigmann H., Hаrtter S. et al. Elevated levels of clozapine in serum after addition of fluvoxamine // J. Clin. Psychopharmacol. - 1994. - Vol. 14. - P. 279-281. 20. Hwang M.Y., Opler L.A. Schizophrenia with obsessive-compulsive features: assessment and treatment // Psych. Ann. - 1994. - Vol. 24. - P. 468-472. 21. Insel T.R., Akiskal H.S. OCD with psychotic features: a phenomenologic analysis // Am. J. Psychiatry. - 1986. - Vol. 143. - P. 15 2 7-15 3 3 . 22. Kane J., Honigfeld G., Singer J. et al. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine // Arch. Gen. Psychiatry. - 1988. - Vol. 45. - P. 789-796. 23. Kapur S., Zipursky R.B., Remington G. et al. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation // Am. J. Psychiatry. - 1998. - Vol. 155. - P. 921-928. 24. Khullar A., Chue P., Tibbo P. Quetiapine and obsessive-compulsive symptoms (OCS): case report and review of atypical antipsychotic-induced OCS // J. Psychiatry Neurosci. - 2001. - Vol. 26. - P. 55-59. 25. Kinon B.J., Basson B.R., Gilmore J.A. et al. Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine // J. Clin. Psychiatry. - 2000. - Vol. 61. - P. 8 3 3 - 8 4 0 . 26. Mahendran R. Obsessive-compulsive symptoms with risperidone // J. Clin. Psychiatry. - 1999. - Vol. 60. - P. 261-263. 27. Margetis B. Aggravation of schizophrenia by clomipramine in a patient with comorbid obsessive-compulsive disorder // Psychopharmacol. Bull. - 2008. - Vol. 41. - P. 9-11. 28. Masand P.S. A review of pharmacologic strategies for switching to atypical antipsychotics. Prim Care Companion // J. Clin. Psychiatry. - 2005. - Vol. 7. - P. 121-129. 29. McEvoy J.P., Lieberman J.A., Perkins D.O. et al. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52week comparison // Am. J. Psychiatry. - 2007. - Vol. 164 (7). - P. 10 5 0 -10 6 0 . 30. Oransky I. Paul Janssen // Lancet. - 2004. - Vol. 363. - P. 251. 31. Poyurovsky M., Weizman A. Intravenous clomipramine for a schizophrenic patient with obsessive-compulsive symptoms // Am. J. Psychiatry. - 1998. - Vol. 155. - P. 1993. 32. Poyurovsky M. Obsessive-compulsive symptoms in schizophrenia: clinical characterization and treatment // Clinical Obsessive-Compulsive Disorders in Adults and Children / Eds R. Hudak, D.D. Dougherty. - Cambridge Univ. Press, 2011. - P. 7 1- 9 1. 33. Reznik I., Sirota P. Obsessive and compulsive symptoms in schizophrenia: a randomized controlled trial with fluvoxamine and neuroleptics // J. Clin. Psychopharmacol. - 2000. - Vol. 20. - P. 410-416. 34. Reznik I., Yavin I., Stryjer R.et al. Clozapine in the treatment of obsessive-compulsive symptoms in schizophrenia patients: a case series study // Pharmacopsychiatry. - 2004. - Vol. 37. - P. 5 2 - 5 6 . 35. Samuels J., Nestadt G., Wolyniec P. et al. Obsessive-compulsive symptoms in schizophrenia // Schizophr. Res. - 1993. - Vol. 9. - P. 139. 36. Zohar J., Kaplan Z., Benjamin J. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients // J. Clin. Psychiatry. - 1993. - Vol. 54. - P. 385-388.

Метрики статей

Загрузка метрик ...

Metrics powered by PLOS ALM